Document Detail

Effects of antegrade cardioplegic infusion with simultaneously controlled coronary sinus occlusion on preservation of regionally ischemic myocardium after acute coronary artery occlusion and reperfusion.
MedLine Citation:
PMID:  3172809     Owner:  NLM     Status:  MEDLINE    
This study was conducted to assess the protective effects of antegrade infusion of cardioplegic solution with simultaneously controlled coronary sinus occlusion on regionally ischemic myocardium after acute coronary occlusion and reperfusion. Twelve sheep were subjected to 1 hour of occlusion of the distal left anterior descending coronary artery. Sheep in group I (n = 6) were subjected only to infusion of potassium crystalloid cardioplegic solution into the aortic root, whereas in group II (n = 6) a stitch was snared around the proximal coronary sinus for its subsequent occlusion during antegrade infusions of cardioplegic solution. All animals were placed on cardiopulmonary bypass. Five hundred milliliters of cardioplegic solution at 4 degrees to 8 degrees C was administered in three divided doses during the total cross-clamp period of 30 minutes. The occlusion of the left anterior descending artery was then released, and the animals were weaned from bypass and studied for an additional 4 hours. Coronary sinus pressure, myocardial temperature, regional function assessed by pairs of ultrasonic crystals, global function assessed by rate of rise of left ventricular pressure and cardiac output, and the area at risk and area of necrosis were determined. The heart was excised at the end of the experiment and stained. Animals treated by the technique of antegrade infusion combined with coronary sinus occlusion had more homogeneous myocardial cooling during cardioplegic infusions and better recovery of the first derivative of left ventricular pressure and regional segment shortening at 90 and 270 minutes of reperfusion than those treated with antegrade infusion alone (p less than 0.01 and p less than 0.05, respectively). The group treated by antegrade infusion of cardioplegic solution combined with coronary sinus occlusion had an area of necrosis/area at risk ratio of 40.5% +/- 1.2%; the antegrade infusion group, 58.3% +/- 4.1% (p less than 0.01). These data suggest that antegrade infusion combined with coronary sinus occlusion may be an improved method of global and regional myocardial protection in the presence of an occluded coronary artery.
S C Sun; S T Raza; S K Tam; R Laurence; L H Cohn
Related Documents :
6608639 - Effects of reperfusion after acute coronary occlusion on the beating, working heart com...
15675979 - Thermogenic effect of amino acids not demonstrated in heart surgery with cardiopulmonar...
22560599 - The electrocardiographic diagnosis of intraventricular blocks coexisting with ventricul...
22051849 - Myocardial performance and its acute response to angiotensin ii infusion in fetal sheep...
8419709 - Impaired endothelium-dependent coronary microvascular relaxation after cold potassium c...
12467819 - Non-depolarizing cardioplegia activates ca2+-atpase in sarcoplasmic reticulum after rep...
17291149 - Complement component c5a predicts restenosis after superficial femoral artery balloon a...
24157289 - Increased risk of acute myocardial infarction in systemic sclerosis: a nationwide popul...
2667419 - Mitral valve prolapse: causes, clinical manifestations, and management.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  The Journal of thoracic and cardiovascular surgery     Volume:  96     ISSN:  0022-5223     ISO Abbreviation:  J. Thorac. Cardiovasc. Surg.     Publication Date:  1988 Oct 
Date Detail:
Created Date:  1988-11-07     Completed Date:  1988-11-07     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  0376343     Medline TA:  J Thorac Cardiovasc Surg     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  626-33     Citation Subset:  AIM; IM    
Department of Surgery, Harvard Medical School, Boston, Mass.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cardioplegic Solutions / administration & dosage*
Cardiopulmonary Bypass
Coronary Vessels*
Heart Arrest, Induced / methods
Myocardial Contraction
Myocardial Reperfusion*
Myocardium / pathology
Potassium / administration & dosage
Potassium Compounds*
Reg. No./Substance:
0/Cardioplegic Solutions; 0/Potassium Compounds; 0/potassium cardioplegic solution; 7440-09-7/Potassium

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tracheobronchial foreign bodies in the Middle East. A Baghdad study.
Next Document:  Perioperative variability of binding of lidocaine, quinidine, and propranolol after cardiac operatio...